Axogen, Inc. — Director's Dealing 2013

Aug 15, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2013-08-14

Reporting Person: Harper John Frederick (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-08-14	Common Stock	P	66666	$3.00	Acquired	214094	Direct

Footnotes

F1: The reporting person purchased these shares in its individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On August 9, the trade date for the public offering and the first day AxoGen shares were traded on the NASDAQ Capital Market, the closing sale price reported by NASDAQ was $2.98 per share. The public offering closed on August 14, 2013, and the closing sale price reported by NASDAQ on August 14, 2013 was $2.97 per share.